Rochester, MN, United States of America

Claire A Schreiber

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Mayo Foundation for Medical Education and Research, University of Pittsburgh. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Claire A Schreiber. Retrieved from https://idiyas.com/inventor/claire-a-schreiber

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Claire A Schreiber

Introduction

Claire A Schreiber is an accomplished inventor based in Rochester, MN (US). She has made significant contributions to the field of viral vector infectivity, showcasing her expertise through her innovative patent.

Latest Patents

Claire A Schreiber holds a patent titled "Methods and materials for increasing viral vector infectivity." This document relates to methods and materials for enhancing the infectivity of viral vectors. Specifically, it discusses the use of spliceosome inhibitors, such as U2 snRNP spliceosome inhibitors like meayamycin B or pladienolide derivative E7107, to improve the infectivity of adeno-associated virus-based vectors.

Career Highlights

Throughout her career, Claire has worked with notable institutions, including the Mayo Foundation for Medical Education and Research and the University of Pittsburgh. Her work has been instrumental in advancing research in viral vector applications.

Collaborations

Some of her notable coworkers include Yasuhiro Ikeda and Toshie Sakuma, who have collaborated with her on various projects.

Conclusion

Claire A Schreiber's innovative work in increasing viral vector infectivity highlights her significant contributions to medical research and technology. Her patent and collaborations reflect her dedication to advancing the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…